Literature DB >> 15238151

Applications of murine and humanized chimaeric monoclonal antibodies for red cell phenotyping.

E Lee1, G Burgess, G R Halverson, T J Huang, M E Reid.   

Abstract

The limited supply of reagent human polyclonal antibodies to high prevalence antigens, like Js(b), is driving the search for alternative reagents. Murine immunoglobulin G (IgG) monoclonal antibodies (Mabs) and their humanized chimaeric IgM isoforms can now be used for typing patients and screening donors. Antigen typing of red blood cells (RBC) with a positive direct antiglobulin test (DAT) is also possible using these antibodies. Blood from patients with sickle cell disease and African donors were tested with reagent anti-Js(b), murine Mab IgG anti-Js(b) [murine immunochemistry monoclonal antibody-8 (MIMA-8)], and humanized chimaeric IgM anti-Js(b) [human immunochemistry monoclonal antibody-8 (HIMA-8)] by haemagglutination and gel cards. RBC samples that were DAT positive were used to evaluate the humanized chimaeric IgM monoclonal anti-Fy(a) (HIMA-19). RBC samples (n = 243) of known Js(b) type were tested in parallel with MIMA-8 and reagent anti-Js(b), and 132 samples were tested with MIMA-8 in gel cards and HIMA-8 by direct tube testing. No discrepant results were obtained. DAT-positive RBC samples (n = 27) were correctly phenotyped using HIMA-19. We conclude that MIMA-8 is suitable for screening donors and typing patient RBCs. Testing MIMA-8 with gel cards containing anti-mouse IgG enables the screening of donors by automated methods. Humanized chimaeric IgM anti-Js(b) and anti-Fy(a) are suitable as typing reagents by direct agglutination methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238151     DOI: 10.1111/j.1365-2141.2004.05019.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Blocking phenomenon occurs with murine monoclonal antibodies (anti-Fy(a)) in a neonate with a positive direct antiglobulin test due to maternal anti-Fy(a).

Authors:  Edmond Lee; Carol Cantwell; Kehinde O Muyibi; Rekha Modasia; Megan Rowley; Helen New
Journal:  Blood Transfus       Date:  2015-01-30       Impact factor: 3.443

2.  'Chameleonic' Serological Findings Leading to Life-Threatening Hemolytic Transfusion Reactions.

Authors:  Ariane Sümnig; Beate Mayer; Volker Kiefel; Andreas Greinacher; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-04       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.